en · de · es · fr · pt
sermorelin-notes.peptides6908.com › Faq › Peptide Identity And Structural Background — What the Evidence Shows

Peptide Identity And Structural Background — What the Evidence Shows

By Editorial Desk · published 2026-01-26 · last reviewed 2026-02-22 · Faq

Everything below concerns melanotan-2. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-02-22. Numbers and descriptions here follow the published literature rather than marketing material.

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.

Background and Mechanism of Melanotan-2

Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.

Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Synthetic cyclic heptapeptide
Molecular massApproximately 1024 g/molDepends on counter-ion content
AppearanceWhite to off-white powderCommonly supplied as a lyophilised solid
SolubilityFreely soluble in waterAlso dissolves in common aqueous buffers
Typical storage-20 degrees Celsius, desiccatedProtect from light and repeated freeze-thaw

Melanotan-2 Identity And Regulatory Status

Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.

Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.

Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.

Related pages on this site

Melanotan-2 Identity and Receptor Pharmacology

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Supporting material

== Habitat == When first discovered, Roseiflexus castenholzii was isolated from the lowest layer of a three layered bacterial mat; the top two layers contained cyanobacteria and Chloroflexus spp. These mats were found in multiple Japanese hot springs ranging in temperature from 45.5 °C to 68.5 °C and with a neutral to alkaline pH range. This bacterium is able to grow photoheterotrophically under anaerobic light conditions and chemoheterotrophically under aerobic dark conditions. Optimal growth conditions for this organism are 50 °C and pH 7.5–8.0. The first isolated type strain was HLO8T (= DSM 13941T = JCM 11240T).

According to Wayman, these two are: (1) the general principle of dependent origination itself, its nidanas and their relationships and (2) how it deals with the particular process of the rebirth of sentient beings.

== Philanthropy == The Foundation has made significant donations to buildings and other works at Downing College Cambridge University. In particular, the Howard Building (1986) and the Howard Lodge (1991) both designed by Quinlan Terry and the Howard Theatre designed by Quinlan and Francis Terry (2009). The Foundation sponsored the book by Tim Rawle: A Classical Adventure – the Architectural History of Downing College, Cambridge. The Foundation also made donations to the Waterford Institute of Technology towards the construction of the Howard Laboratory (an analytical chemical laboratory) and the Howard Gate at Carriganore House, on the west campus of the Waterford Institute of Technology.

=== Machinima === Garry's Mod has been used as the basis for machinima. One of the more notable examples is Half-Life: Full Life Consequences, which is based on a fan fiction set in the Half-Life universe, penned in 2008 by a user named Squirrelking. YouTube user Djy1991 used Garry's Mod to animate the fan fiction, using literal interpretations of some of the work's typographical errors and awkward grammar.

== Function == Vitellogenin provides the major egg yolk protein that is a source of nutrients during early development of egg-laying (oviparous) vertebrates and invertebrates. Although vitellogenin also carries some lipid for deposition in the yolk, the primary mechanism for deposition of yolk lipid is instead via VLDLs, at least in birds and reptiles. Vitellogenin precursors are multi-domain apolipoproteins (proteins that bind to lipids to form lipoproteins), that are cleaved into distinct yolk proteins. Different vitellogenin proteins exist, which are composed of variable combinations of yolk protein components; however, the cleavage sites are conserved.

Sources: en.wikipedia.org

Supporting material

== History == 1. FC Lokomotive Leipzig claims to be the successor to the VfB Leipzig and SC Sportbrüder Leipzig teams, established in 1896 and 1893, respectively, and therefore, one of the oldest clubs of the German Football Association. However, they are not nominal successors. In 2018, 1. FC Lokomotive announced a merger with the formally extant but dormant VfB Leipzig in order to be entitled to the forerunner's titles. Due to the significant breaks and turmoil in the club's history, especially during the post-World War II era, their exact establishment date remains a source of contention.

Bowfin are physostomes, meaning they have a small "pneumatic duct" that connects their swim bladders to their digestive tracts. This allows them, like lungfish, to "breathe" in two ways; they can extract oxygen from the water when breathing through their gills, but can also break the water's surface to breathe or gulp air through the pneumatic duct. When performing low-level physical activity, bowfin obtain more than half of their oxygen from breathing air. The fish have two distinct air-breathing mechanisms used to ventilate the gas bladder. Air-breathing type I is consistent with the action of exhale/inhale exchange, stimulated by either air or water hypoxia, to regulate O2 gas exchange; type II air breaths are inhalation alone, which is believed to regulate gas bladder volume to control buoyancy. Bimodal respiration helps bowfin survive and maintain their metabolic rate in hypoxic conditions. Bowfin breathe air more frequently when they are in darkness, and correspondingly more active. Bowfin blood can adapt to warm, acidic waters. The fish becomes inactive in waters below 10 °C (50 °F); at this temperature, they breathe almost no air, but with increasing temperature, their air breathing increases. Their preferred temperature range is between 12 and 26 °C (54 and 79 °F), with 18 °C (64 °F) the temperature of maximum activity. Air breathing is at a maximum in the range 18.4–29.6 °C (65.1–85.3 °F). Bowfin do not use central chemoreceptor regulation for respiration control.

I abolished feudalism and restored equality to all religion and before the law. I fought the decrepit monarchies of the Old Regime because the alternative was the destruction of all this. I purified the Revolution."

"Alzheimer's Disease Research Timeline – Alzforum". www.alzforum.org. "Alzheimer's Disease Brain Cell Atlas- brain-map.org". portal.brain-map.org. "What's the deal with Alzheimer's disease and amyloid?". For decades, scientists have concentrated on what now looks to be a blind alley. The Amyloid Mafia. Jonathan M. Gitlin, Ars Technica, Apr 15, 2026

Sources: en.wikipedia.org

Frequently asked questions

What is Melanotan-2 chemically?

It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.

How does it differ from the natural hormone?

It is shorter than the native hormone and carries a cyclic constraint that improves stability. These changes raise receptor potency and slow breakdown relative to the naturally occurring peptide.

When was Melanotan-2 first described?

Published accounts date its development to the 1980s, when researchers were generating analogues of melanocyte-stimulating hormone. That work aimed to produce more stable compounds for studying pigmentation biology.

Is melanotan-2 a natural hormone?

No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.

Network